View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Cetuximab 400 / Paclitaxel 40 / Carboplatin 2 / Radiation, Head and Neck Tumors, Cycle 1
Protocol-ID: 622 V1.1 (Mini), CETU400/PACL40/CRBP2/Radiation, Head and Neck Tumors, C1Indication(s)
- Head and Neck Tumors (Squamous Cell); ICD-10 C76.0
- Nasopharyngeal Carcinoma; ICD-10 C11.8, C11.9, C11.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 25.02.2020